Literature DB >> 27126904

Stable polyanhydride synthesized from sebacic acid and ricinoleic acid.

Moran Haim-Zada1, Arijit Basu1, Tal Hagigit2, Ron Schlinger2, Michael Grishko3, Alexander Kraminsky3, Ezra Hanuka3, Abraham J Domb4.   

Abstract

Poly(anhydride) are unstable and prone to hydrolytic degradation and depolymerisation via anhydride interchange. They are stored at -20°C, packed under inert atmosphere until use. We synthesized a new poly(anhydride) from ricinoleic (RA) and sebacic (SA) acid with alternating ester-anhydride structure that is stable at 25°C for over 18months. The copolymer is also stable in chloroform solution and under γ-irradiation. The polymer hydrolyses through anhydride cleavage lasting ~7days to form oligoesters, which are stable for >30days. The release of gentamycin from the synthesized alternate polymer matrix is sustained compared to the random copolymer.
Copyright © 2016 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Alternating polymers; Anhydride interchange; Drug release; Poly anhydrides; Ricinoleic acid; Sebacic acid

Mesh:

Substances:

Year:  2016        PMID: 27126904     DOI: 10.1016/j.jconrel.2016.04.036

Source DB:  PubMed          Journal:  J Control Release        ISSN: 0168-3659            Impact factor:   9.776


  3 in total

1.  Treatment of Experimental Cerebral Malaria by Slow Release of Artemisone From Injectable Pasty Formulation.

Authors:  Jacob Golenser; Nadeen Salaymeh; Abd Alroof Higazi; Mohammed Alyan; Mahran Daif; Ron Dzikowski; Abraham J Domb
Journal:  Front Pharmacol       Date:  2020-06-12       Impact factor: 5.810

2.  Synthesis of Aliphatic Polyanhydrides with Controllable and Reproducible Molecular Weight.

Authors:  Radhakanta Ghosh; Yuvaraj Arun; Peter Siman; Abraham J Domb
Journal:  Pharmaceutics       Date:  2022-07-04       Impact factor: 6.525

3.  Poly(ester-anhydrides) Derived from Esters of Hydroxy Acid and Cyclic Anhydrides.

Authors:  Yuvaraj Arun; Radhakanta Ghosh; Abraham J Domb
Journal:  Biomacromolecules       Date:  2022-07-26       Impact factor: 6.978

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.